Status:

COMPLETED

To Demonstrate the Relative Bioavailability of Cyclobenzaprine HCl Tablets

Lead Sponsor:

Sandoz

Conditions:

Depression

Eligibility:

MALE

19-50 years

Phase:

PHASE1

Brief Summary

To demonstrate the relative bioavailability of Cyclobenzaprine HCl tablets.

Eligibility Criteria

Inclusion

  • No clinically significant abnormal finding on physical exam, medical history, or clinical laboratory results on screening.

Exclusion

  • Positive test results for HIV or hepatitis B or C.
  • Treatment for drug or alcohol dependence.

Key Trial Info

Start Date :

November 1 1988

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 1988

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT00913419

Start Date

November 1 1988

End Date

December 1 1988

Last Update

March 28 2017

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.